Dr. Carl Deirmengian, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 Enterprise Dr Fl 2, Limerick, PA 19468 Phone: 267-339-3558 Fax: 672-339-3763 |
H William Schaaf, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 Enterprise Dr Fl 2, Limerick, PA 19468 Phone: 267-339-3558 Fax: 267-339-3763 |
News Archive
Dainippon Sumitomo Pharma Co., Ltd. (DSP) announced on October 9 that it has decided to establish an anti-cancer drugs sales company in the United States as a wholly-owned subsidiary of DSP's 100% owned U.S. holding company.
Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines.
ARIAD Pharmaceuticals, Inc. today announced the initial clinical results on its investigational, tyrosine-kinase inhibitor, AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health.
› Verified 4 days ago